Is There a Role for Active Surveillance in Low-Risk Prostate Cancer?
Urol Int 2015 17;95(2):125-31. Epub 2015 Mar 17.
Background: Active surveillance (AS) represents an expectant treatment strategy for clinically localized prostate cancer (PCa) with low-risk features.
Objective: The actual management as well as the pros and cons of AS were evaluated.
Expression patterns of candidate susceptibility genes HNF1β and CtBP2 in prostate cancer: association with tumor progression.
Urol Oncol 2014 May 12;32(4):426-32. Epub 2013 Dec 12.
Human prostate cancer ZIP1/zinc/citrate genetic/metabolic relationship in the TRAMP prostate cancer animal model.
Cancer Biol Ther 2011 Dec 15;12(12):1078-84. Epub 2011 Dec 15.
Department of Oncology and Diagnostic Sciences, Dental School and Greenebaum Cancer Center, University of Maryland, Baltimore, MD, USA.
Observations of prostate specific antigen doubling time in Japanese patients with nonmetastatic prostate carcinoma.
Department of Urology, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan.
Background: To understand better the natural history and biology of prostate carcinoma occurring in Japanese patients, the authors attempted to define changes with time in prostate specific antigen (PSA) measurements in 48 men with clinically resectable T1-T3 nonmetastatic disease.
Diagnostic correlations with whole mounts of radical prostatectomy specimens.
[Biology and natural history of prostatic cancer: necessity of early diagnostic screening].